{"id":"https://openalex.org/W4361237152","doi":"https://doi.org/10.1158/0008-5472.c.6508886","title":"Data from T Cells Deficient in Diacylglycerol Kinase \u03b6 Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia","display_name":"Data from T Cells Deficient in Diacylglycerol Kinase \u03b6 Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361237152","doi":"https://doi.org/10.1158/0008-5472.c.6508886"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6508886","doi":"https://doi.org/10.1158/0008-5472.c.6508886","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6508886","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.6508886","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019140875","display_name":"Weiqing Jing","orcid":"https://orcid.org/0000-0002-3008-9873","observed_orcids":["https://orcid.org/0000-0002-3008-9873"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Weiqing Jing","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040926018","display_name":"Jill A. Gershan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jill A. Gershan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103858595","display_name":"Sandra Holzhauer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra Holzhauer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"James Weber","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Weber","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078070294","display_name":"Katie A. Palen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katie Palen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020902740","display_name":"Laura McOlash","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura McOlash","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036613947","display_name":"Kirthi Pulakanti","orcid":"https://orcid.org/0000-0003-1167-8493","observed_orcids":["https://orcid.org/0000-0003-1167-8493"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kirthi Pulakanti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016285405","display_name":"Erin Wesley","orcid":"https://orcid.org/0000-0001-6990-759X","observed_orcids":["https://orcid.org/0000-0001-6990-759X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erin Wesley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031833096","display_name":"Sridhar Rao","orcid":"https://orcid.org/0000-0003-2688-9541","observed_orcids":["https://orcid.org/0000-0003-2688-9541"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sridhar Rao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077602611","display_name":"Bryon D. Johnson","orcid":"https://orcid.org/0000-0001-7416-3396","observed_orcids":["https://orcid.org/0000-0001-7416-3396"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bryon D. Johnson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069691970","display_name":"Matthew John Riese","orcid":"https://orcid.org/0000-0002-2423-0017","observed_orcids":["https://orcid.org/0000-0002-2423-0017"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew J. Riese","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5062999725341797,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5062999725341797,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.22010000050067902,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.1340000033378601,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diacylglycerol-kinase-zeta","display_name":"diacylglycerol kinase zeta","score":0.996999979019165},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.859000027179718},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.7440000176429749},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/myeloid-leukemia","display_name":"myeloid leukemia","score":0.9409999847412109},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.781000018119812},{"id":"https://openalex.org/keywords/antigen-escape","display_name":"antigen escape","score":0.8320000171661377}],"concepts":[{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.6170963048934937},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5837183594703674},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.553043782711029},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5211758017539978},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5067537426948547},{"id":"https://openalex.org/C36020004","wikidata":"https://www.wikidata.org/wiki/Q106951674","display_name":"Diacylglycerol kinase","level":4,"score":0.49487918615341187},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4721943140029907},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4425642788410187},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33382827043533325},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3311358094215393},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.18544334173202515},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1729646623134613},{"id":"https://openalex.org/C195794163","wikidata":"https://www.wikidata.org/wiki/Q420877","display_name":"Protein kinase C","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6508886","doi":"https://doi.org/10.1158/0008-5472.c.6508886","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6508886","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6508886","doi":"https://doi.org/10.1158/0008-5472.c.6508886","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6508886","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2755715876","https://openalex.org/W3105920448","https://openalex.org/W4241356124","https://openalex.org/W4241482897","https://openalex.org/W4308397175","https://openalex.org/W3191401694","https://openalex.org/W2606271783","https://openalex.org/W4415900344","https://openalex.org/W4404064541","https://openalex.org/W2796046885"],"abstract_inverted_index":{"Abstract":[0],"Efforts":[1],"to":[2,77,88,170],"improve":[3],"the":[4,24,37,49,97,119,144],"efficacy":[5,145],"of":[6,27,53,99,109,121,132,146,165],"adoptive":[7,147],"T-cell":[8,112,148],"therapies":[9,13,152],"and":[10,123,149],"immune":[11,150,171],"checkpoint":[12,151,172],"in":[14,36,64,126,153],"myelogenous":[15],"leukemia":[16,59,154],"are":[17],"desired.":[18],"In":[19,48],"this":[20,82],"study,":[21],"we":[22,56,94],"evaluated":[23],"antileukemia":[25],"activity":[26,98],"adoptively":[28,100],"transferred":[29,73,101],"polyclonal":[30],"cancer":[31],"antigen-reactive":[32],"T":[33,71,103,116],"cells":[34,72,104,117],"deficient":[35],"regulator":[38],"diacylglycerol":[39],"kinase":[40],"zeta":[41],"(DGK\u03b6)":[42],"with":[43,91,130],"or":[44,168],"without":[45],"PD-1/PD-L1":[46],"blockade.":[47,173],"C1498":[50],"mouse":[51],"model":[52],"myeloid":[54],"leukemia,":[55],"showed":[57],"that":[58,96,139,159],"was":[60,86],"eradicated":[61],"more":[62],"effectively":[63],"DGK\u03b6-deficient":[65,75,115],"(DGK\u03b6\u2212/\u2212)":[66],"mice":[67,76,89],"than":[68],"wild-type":[69,78],"mice.":[70],"from":[74],"tumor-bearing":[79],"recipients":[80],"conferred":[81],"benefit.":[83],"Leukemia":[84],"clearance":[85],"similar":[87],"treated":[90],"anti-PD-L1.":[92,133],"Strikingly,":[93],"found":[95],"DGK\u03b6\u2212/\u2212":[102],"relied":[105],"partly":[106],"on":[107],"induction":[108],"sustainable":[110],"host":[111],"immunity.":[113],"Transferring":[114],"increased":[118],"levels":[120],"IFN\u03b3":[122],"other":[124],"cytokines":[125],"recipient":[127],"mice,":[128],"especially":[129],"coadministration":[131],"Overall,":[134],"our":[135],"results":[136],"offered":[137],"evidence":[138],"targeting":[140,161],"DGK\u03b6":[141,160],"may":[142],"leverage":[143],"treatment.":[155],"Furthermore,":[156],"they":[157],"suggest":[158],"might":[162],"decrease":[163],"risks":[164],"antigen":[166],"escape":[167],"resistance":[169],"Cancer":[174],"Res;":[175],"77(20);":[176],"5676\u201386.":[177],"\u00a92017":[178],"AACR.":[179]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2023-03-31T00:00:00"}